We conclude that pitaya may act on selective ER-responsive breast cancer cells by targeting multiple tumorigenic pathways leading to cell cycle arrest and apoptosis and probably suppress the expression of estrogen and progesterone receptors. Here, PGR is linked to breast cancer.